- Mallinckrodt (NYSE:MNK) closed down ~19% Wednesday after announcing earlier in the day it would initiate voluntary prepackaged Chapter 11 proceedings.
- The bankruptcy marks the second for the troubled pharma in three years.
- Mallinckrodt (MNK) is deep in debt due to settlements related to its alleged role in the nation's opioid crisis.
- A restructuring plan will reduce the company's total funded debt by about $1.9B and increase free cash flow generation.
Mallinckrodt falls 19% following planned bankruptcy filing
Recommended For You
More Trending News
About MNKTQ Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
MNKTQ | - | - |
Mallinckrodt plc |